Why Is Glenmark Pharmaceuticals Limited (BSE: GLENMARK.BO) Stock Up Today?

Glenmark Pharmaceuticals Limited (BSE: GLENMARK.BO) Summary

Glenmark Pharmaceuticals Limited (BSE: GLENMARK.BO) is trading down -0.82% at $2,306.00, reflecting a negative shift in investor sentiment today. The stock opened at $2,339.95 and has moved between $2,304.85 and $2,346.60 so far.

Trading volume is 6291, which is 72% below its average, and the price action suggests selling interest.

Technically, GLENMARK.BO on the BSE is trading above its 50-day moving average of $2,232.34 and above its 200-day moving average of $2,130.54, indicating short-term and long-term strength.

Meyka's AI assigns GLENMARK.BO a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +5.92% in 1 month ($2,442.44), +5.32% in 1 year ($2,428.75), and +85.01% in 5 years ($4,266.37).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the BSE.
Stay informed and make better investment decisions.